4.5 Review

Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets

Journal

FEBS LETTERS
Volume 581, Issue 19, Pages 3665-3674

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2007.04.033

Keywords

Hsp27; alpha B-crystallin; neurodegenerative diseases; myopathies; cancers

Ask authors/readers for more resources

Hsp27 and alpha B-crystallin are molecular chaperones that are constitutively expressed in several mammalian cells, particularly in pathological conditions. These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties and are tumorigenic when expressed in cancer cells. This review summarizes the current knowledge about Hsp27 and alpha B-crystallin and the implications, either positive or deleterious, of these proteins in pathologies such as neurodegenerative diseases, myopathies, asthma, cataracts and cancers. Approaches towards therapeutic strategies aimed at modulating the expression and/or the activities of Hsp27 and aB-crystallin are presented. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available